483 related articles for article (PubMed ID: 2420482)
21. Fibrinolysis--a review.
Kane KK
Ann Clin Lab Sci; 1984; 14(6):443-9. PubMed ID: 6239587
[TBL] [Abstract][Full Text] [Related]
22. [Molecular mechanisms of thrombolytic therapy].
Lijnen HR; Collen D
Haemostasis; 1986; 16 Suppl 4():3-15. PubMed ID: 2945768
[No Abstract] [Full Text] [Related]
23. Effects of kringles derived from human plasminogen on fibrinolysis in vitro.
Sugiyama N; Iwamoto M; Abiko Y
Thromb Res; 1987 Aug; 47(4):459-68. PubMed ID: 2821651
[TBL] [Abstract][Full Text] [Related]
24. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
Wu JH; Diamond SL
Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
[TBL] [Abstract][Full Text] [Related]
25. The human plasma fibrinolytic system: regulation and control.
Robbins KC
Mol Cell Biochem; 1978 Aug; 20(3):149-57. PubMed ID: 151804
[TBL] [Abstract][Full Text] [Related]
26. [Inhibition of esterase by L-lysine, the activator and fibrinolytic activity of the plasmin-streptokinase activator complex].
Aĭsina RB; Gaĭsarian ES; Snitko IaE; Varfolomeev SD
Bioorg Khim; 1994 Feb; 20(2):182-9. PubMed ID: 8155080
[TBL] [Abstract][Full Text] [Related]
27. Pharmacology of fibrinolysis.
Haire WD
Chest; 1992 Apr; 101(4 Suppl):91S-97S. PubMed ID: 1555484
[TBL] [Abstract][Full Text] [Related]
28. Fibrin-specific thrombolytic agents.
Collen D
Schweiz Med Wochenschr; 1987 Nov; 117(46):1791-8. PubMed ID: 3122317
[TBL] [Abstract][Full Text] [Related]
29. Preclinical pharmacological evaluation of anisoylated plasminogen streptokinase activator complex.
Ferres H
Drugs; 1987; 33 Suppl 3():33-50. PubMed ID: 3315613
[TBL] [Abstract][Full Text] [Related]
30. The mechanism of activation of plasminogen at the fibrin surface by tissue-type plasminogen activator in a plasma milieu in vitro. Role of alpha 2-antiplasmin.
Rouy D; Anglés-Cano E
Biochem J; 1990 Oct; 271(1):51-7. PubMed ID: 1699517
[TBL] [Abstract][Full Text] [Related]
31. Fibrinolysis: the key to new pathogenetic mechanisms.
Zorio E; Gilabert-Estellés J; España F; Ramón LA; Cosín R; Estellés A
Curr Med Chem; 2008; 15(9):923-9. PubMed ID: 18473800
[TBL] [Abstract][Full Text] [Related]
32. The plasmin-antiplasmin system: structural and functional aspects.
Schaller J; Gerber SS
Cell Mol Life Sci; 2011 Mar; 68(5):785-801. PubMed ID: 21136135
[TBL] [Abstract][Full Text] [Related]
33. Effect of a synthetic carboxy-terminal peptide of alpha(2)-antiplasmin on urokinase-induced fibrinolysis.
Lee KN; Jackson KW; McKee PA
Thromb Res; 2002 Feb; 105(3):263-70. PubMed ID: 11927133
[TBL] [Abstract][Full Text] [Related]
34. [Structure, function and use of fibrinolysis-promoting and inhibiting factors].
Bachmann F
Arzneimittelforschung; 1988 Mar; 38(3A):474-8. PubMed ID: 3134901
[TBL] [Abstract][Full Text] [Related]
35. A comparative study of the efficacy and specificity of tissue plasminogen activator and pro-urokinase: demonstration of synergism and of different thresholds of non-selectivity.
Gurewich V; Pannell R
Thromb Res; 1986 Oct; 44(2):217-28. PubMed ID: 3097872
[TBL] [Abstract][Full Text] [Related]
36. [Blood coagulation mechanism from the viewpoint of molecular biochemistry: Mechanism of fibrinolysis].
Matsuda T
Rinsho Byori; 1985 Sep; 33(9):982-8. PubMed ID: 2416968
[No Abstract] [Full Text] [Related]
37. Nephrotic syndrome with renal vein thrombosis: pathogenetic importance of a plasmin inhibitor (alpha 2-antiplasmin).
Du XH; Glas-Greenwalt P; Kant KS; Allen CM; Hayes S; Pollak VE
Clin Nephrol; 1985 Oct; 24(4):186-91. PubMed ID: 3933871
[TBL] [Abstract][Full Text] [Related]
38. Regulation by alpha 2-antiplasmin and fibrin of the activation of plasminogen with recombinant staphylokinase in plasma.
Silence K; Collen D; Lijnen HR
Blood; 1993 Aug; 82(4):1175-83. PubMed ID: 7688990
[TBL] [Abstract][Full Text] [Related]
39. [The fibrinolytic system and its activators].
Seifried E
Z Gesamte Inn Med; 1993; 48(6-7):272-82. PubMed ID: 8333223
[TBL] [Abstract][Full Text] [Related]
40. Methods for studying fibrinolytic pathway components in human plasma.
Wohl RC; Sinio L; Robbins KC
Thromb Res; 1982 Sep; 27(5):523-35. PubMed ID: 6217585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
